Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 3/2018

Ausgabe 3/2018

Inhaltsverzeichnis ( 24 Artikel )

03.04.2018 | Review | Ausgabe 3/2018

Male secretory breast cancer: case in a 6-year-old boy with a peculiar gene duplication and review of the literature

M. Ghilli, M. D. Mariniello, C. Scatena, l. Dosa, G. Traficante, A. Tamburini, C. Caporalini, A. M. Buccoliero, F. Facchini, L. Colizzi, A. Quattrini Li, E. Landucci, G. Manca, A. G. Naccarato, D. Caramella, C. Favre, M. Roncella

13.04.2018 | Review | Ausgabe 3/2018

Effects of physical exercise after treatment of early breast cancer: systematic review and meta-analysis

Frederico Soares Falcetta, Henrique de Araújo Vianna Träsel, Fernando Kude de Almeida, Mariana Rangel Ribeiro Falcetta, Maicon Falavigna, Daniela Dornelles Rosa

28.03.2018 | Preclinical study | Ausgabe 3/2018 Open Access

MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis

Pranabananda Dutta, Marianna Sarkissyan, Kimberly Paico, Yanyuan Wu, Jaydutt V. Vadgama

30.03.2018 | Preclinical study | Ausgabe 3/2018 Open Access

Association of reproductive history with breast tissue characteristics and receptor status in the normal breast

Marike Gabrielson, Flaminia Chiesa, Catharina Behmer, Katarina Rönnow, Kamila Czene, Per Hall

05.04.2018 | Preclinical study | Ausgabe 3/2018

Use of dual mTOR inhibitor MLN0128 against everolimus-resistant breast cancer

Karineh Petrossian, Duc Nguyen, Chiao Lo, Noriko Kanaya, George Somlo, Yvonne Xiaoyong Cui, Chiun-Sheng Huang, Shiuan Chen

24.04.2018 | Preclinical study | Ausgabe 3/2018

Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness

Hidetaka Shima, Kumiko Kida, Shoko Adachi, Akimitsu Yamada, Sadatoshi Sugae, Kazutaka Narui, Yohei Miyagi, Mayuko Nishi, Akihide Ryo, Soichiro Murata, Hideki Taniguchi, Yasushi Ichikawa, Takashi Ishikawa, Itaru Endo

02.04.2018 | Clinical trial | Ausgabe 3/2018

Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients

Marc D. Schwartz, Beth N. Peshkin, Claudine Isaacs, Shawna Willey, Heiddis B. Valdimarsdottir, Rachel Nusbaum, Gillian Hooker, Suzanne O’Neill, Lina Jandorf, Scott P. Kelly, Jessica Heinzmann, Aliza Zidell, Katia Khoury

09.04.2018 | Clinical trial | Ausgabe 3/2018

Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis

Sasagu Kurozumi, Chitra Joseph, Sultan Sonbul, Kylie L. Gorringe, Marian Pigera, Mohammed A. Aleskandarany, Maria Diez-Rodriguez, Christopher C. Nolan, Takaaki Fujii, Ken Shirabe, Hiroyuki Kuwano, Sarah Storr, Stewart G. Martin, Ian O. Ellis, Andrew R. Green, Emad A. Rakha

13.04.2018 | Clinical trial | Ausgabe 3/2018 Open Access

Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib + letrozole: results from MONALEESA-2

Sunil Verma, Joyce O’Shaughnessy, Howard A. Burris, Mario Campone, Emilio Alba, David Chandiwana, Anand A. Dalal, Santosh Sutradhar, Mauricio Monaco, Wolfgang Janni

19.04.2018 | Clinical trial | Ausgabe 3/2018

A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated C-reactive protein, a marker of systemic inflammation

Joyce O’Shaughnessy, Angela DeMichele, Cynthia X. Ma, Paul Richards, Denise A. Yardley, Gail Shaw Wright, Kevin Kalinsky, Ronald Steis, Sami Diab, Gerard Kennealey, Ryan Geschwindt, Wei Jiang, Hope S. Rugo

24.04.2018 | Clinical trial | Ausgabe 3/2018

Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy

Waqar Haque, Vivek Verma, Sandra Hatch, V. Suzanne Klimberg, E. Brian Butler, Bin S. Teh

24.04.2018 | Clinical trial | Ausgabe 3/2018

Impact of port site scar on perception of patients with breast cancer: patient-reported outcomes

Amy Voci, David Lee, Emily Ho, Rebecca Crane-Okada, Maggie DiNome

26.04.2018 | Clinical trial | Ausgabe 3/2018 Open Access

FFPE breast tumour blocks provide reliable sources of both germline and malignant DNA for investigation of genetic determinants of individual tumour responses to treatment

Anna Wilkins, Ritika Chauhan, Alistair Rust, Alex Pearson, Frances Daley, Floriana Manodoro, Kerry Fenwick, Judith Bliss, John Yarnold, Navita Somaiah

05.04.2018 | Epidemiology | Ausgabe 3/2018 Open Access

Effect of eribulin on patients with metastatic breast cancer: multicenter retrospective observational study in Taiwan

Kun-Ming Rau, Fu Ou-Yang, Ta-Chung Chao, Yao-Lung Kuo, Tsui-Fen Cheng, Tsu-Yi Chao, Dar-Ren Chen, Yen-Dun Tzeng, Being-Whey Wang, Chun-Yu Liu, Ming-Hung Hu, Yin-Che Lu, Wei-Jen Ou, Chin-Ho Kuo, Chieh-Han Chuang, Jung-Yu Kan, Fang-Ming Chen, Ming-Feng Hou

05.04.2018 | Epidemiology | Ausgabe 3/2018

Understanding racial/ethnic differences in breast cancer-related physical well-being: the role of patient–provider interactions

Devon K. Check, Neetu Chawla, Marilyn L. Kwan, Laura Pinheiro, Janise M. Roh, Isaac J. Ergas, Anita L. Stewart, Tatjana Kolevska, Christine Ambrosone, Lawrence H. Kushi

10.04.2018 | Epidemiology | Ausgabe 3/2018

Pre-diagnostic changes in body mass index and mortality among breast cancer patients

Signe Benzon Larsen, Maia Torstensson, Line Kenborg, Jane Christensen, Niels Kroman, Susanne Oksbjerg Dalton, Anne Tjønneland, Christoffer Johansen, Pernille Envold Bidstrup

12.04.2018 | Epidemiology | Ausgabe 3/2018

An estrogen-related lifestyle score is associated with risk of postmenopausal breast cancer in the PLCO cohort

Mark A. Guinter, Alexander C. McLain, Anwar T. Merchant, Dale P. Sandler, Susan E. Steck

18.04.2018 | Epidemiology | Ausgabe 3/2018

Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system

Candyce H. Kroenke, Dawn L. Hershman, Scarlett L. Gomez, Sara R. Adams, Elizabeth H. Eldridge, Marilyn L. Kwan, Isaac J. Ergas, Ai Kubo, Lawrence H. Kushi

24.04.2018 | Epidemiology | Ausgabe 3/2018 Open Access

Uptake of breast cancer preventive therapy in the UK: results from a multicentre prospective survey and qualitative interviews

Julia Hackett, Rachael Thorneloe, Lucy Side, Michael Wolf, Rob Horne, Jack Cuzick, Samuel G. Smith

23.04.2018 | Epidemiology | Ausgabe 3/2018

Bilateral mastectomies: can a co-surgeon technique offer improvements over the single-surgeon method?

Melissa Anne Mallory, Constantine Tarabanis, Eric Schneider, Suniti Nimbkar, Mehra Golshan

24.04.2018 | Epidemiology | Ausgabe 3/2018 Open Access

The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer

Victoria Sopik, Steven A. Narod

24.04.2018 | Epidemiology | Ausgabe 3/2018

Physician peer group characteristics and timeliness of breast cancer surgery

Jacqueline Bachand, Pamela R. Soulos, Jeph Herrin, Craig E. Pollack, Xiao Xu, Xiaomei Ma, Cary P. Gross

30.04.2018 | Epidemiology | Ausgabe 3/2018

Menopausal hormone therapy and the risk of breast cancer by histological type and race: a meta-analysis of randomized controlled trials and cohort studies

Sohyun Kim, Yeonsook Ko, Hwa Jeong Lee, Jung-eun Lim

02.05.2018 | Brief Report | Ausgabe 3/2018

A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer

Anuhya Kommalapati, Sri Harsha Tella, Gaurav Goyal, Apar Kishor Ganti, Jairam Krishnamurthy, Pavan Kumar Tandra

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise